Hodogaya Chemical Co., Ltd. (TYO:4112)
Japan · Delayed Price · Currency is JPY 2,265.00
-77.00 (-3.29%)
Mar 4, 2026, 3:30 PM JST
Hodogaya Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 45,790 | 48,578 | 44,261 | 43,324 | 41,879 | 41,199 | |
Revenue Growth (YoY) | -8.16% | 9.75% | 2.16% | 3.45% | 1.65% | 9.08% |
Cost of Revenue | 28,683 | 29,378 | 27,162 | 26,654 | 24,221 | 25,125 |
Gross Profit | 17,107 | 19,200 | 17,099 | 16,670 | 17,658 | 16,074 |
Selling, General & Admin | 8,455 | 8,391 | 7,908 | 7,864 | 7,221 | 7,132 |
Research & Development | 5,638 | 5,638 | 5,011 | 4,939 | 3,859 | 3,384 |
Amortization of Goodwill & Intangibles | 12 | 12 | 12 | 12 | 11 | 3 |
Operating Expenses | 14,388 | 14,324 | 13,147 | 12,968 | 11,236 | 10,629 |
Operating Income | 2,719 | 4,876 | 3,952 | 3,702 | 6,422 | 5,445 |
Interest Expense | -100 | -81 | -75 | -52 | -47 | -51 |
Interest & Investment Income | 502 | 505 | 468 | 423 | 259 | 207 |
Currency Exchange Gain (Loss) | -21 | -437 | 276 | 45 | 212 | 63 |
Other Non Operating Income (Expenses) | 49 | -95 | 89 | 92 | 66 | 176 |
EBT Excluding Unusual Items | 3,149 | 4,768 | 4,710 | 4,210 | 6,912 | 5,840 |
Gain (Loss) on Sale of Investments | 3 | 139 | - | 50 | - | -36 |
Gain (Loss) on Sale of Assets | 24 | 6 | - | 68 | 23 | 17 |
Asset Writedown | -34 | -83 | -18 | -39 | -546 | -17 |
Other Unusual Items | 1 | 1 | - | -19 | -167 | -116 |
Pretax Income | 3,143 | 4,831 | 4,692 | 4,270 | 6,222 | 5,688 |
Income Tax Expense | -503 | 254 | 956 | 1,081 | 1,445 | 930 |
Earnings From Continuing Operations | 3,646 | 4,577 | 3,736 | 3,189 | 4,777 | 4,758 |
Minority Interest in Earnings | -1,360 | -1,399 | -1,256 | -966 | -1,526 | -1,639 |
Net Income | 2,286 | 3,178 | 2,480 | 2,223 | 3,251 | 3,119 |
Net Income to Common | 2,286 | 3,178 | 2,480 | 2,223 | 3,251 | 3,119 |
Net Income Growth | -39.84% | 28.14% | 11.56% | -31.62% | 4.23% | 67.87% |
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 | 16 |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 16 | 16 |
Shares Change (YoY) | 0.03% | 0.14% | 0.17% | 0.05% | 0.06% | 0.13% |
EPS (Basic) | 143.78 | 199.99 | 156.27 | 140.31 | 205.30 | 197.08 |
EPS (Diluted) | 143.78 | 199.99 | 156.27 | 140.31 | 205.30 | 197.08 |
EPS Growth | -39.89% | 27.97% | 11.38% | -31.66% | 4.17% | 67.66% |
Free Cash Flow | 575 | 262 | 2,996 | -2,041 | 4,396 | 3,071 |
Free Cash Flow Per Share | 36.17 | 16.49 | 188.79 | -128.82 | 277.61 | 194.04 |
Dividend Per Share | 22.500 | 45.000 | 37.500 | 32.500 | 30.000 | 25.000 |
Dividend Growth | -45.45% | 20.00% | 15.38% | 8.33% | 20.00% | - |
Gross Margin | 37.36% | 39.52% | 38.63% | 38.48% | 42.16% | 39.02% |
Operating Margin | 5.94% | 10.04% | 8.93% | 8.54% | 15.33% | 13.22% |
Profit Margin | 4.99% | 6.54% | 5.60% | 5.13% | 7.76% | 7.57% |
Free Cash Flow Margin | 1.26% | 0.54% | 6.77% | -4.71% | 10.50% | 7.45% |
EBITDA | 6,082 | 7,893 | 6,351 | 5,644 | 8,094 | 6,951 |
EBITDA Margin | 13.28% | 16.25% | 14.35% | 13.03% | 19.33% | 16.87% |
D&A For EBITDA | 3,363 | 3,017 | 2,399 | 1,942 | 1,672 | 1,506 |
EBIT | 2,719 | 4,876 | 3,952 | 3,702 | 6,422 | 5,445 |
EBIT Margin | 5.94% | 10.04% | 8.93% | 8.54% | 15.33% | 13.22% |
Effective Tax Rate | - | 5.26% | 20.38% | 25.32% | 23.22% | 16.35% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.